Doença coronária e SCA
25 ensaiosREBOOT2025TREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT-CNIC)DanGer Shock2024Microaxial Flow Pump in Infarct-Related Cardiogenic ShockREDUCE-AMI2024Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial InfarctionORBITA-22023A Placebo-Controlled Trial of PCI for Stable AnginaFAME 32022Fractional flow reserve versus Angiography for Multivessel Evaluation 3REVIVED-BCIS22022REVascularization for Ischemic VEntricular Dysfunction — British Cardiovascular Intervention Society-2ISCHEMIA2020International Study of Comparative Health Effectiveness with Medical and Invasive ApproachesISAR-REACT 52019Ticagrelor or Prasugrel in Patients with Acute Coronary SyndromesCOMPLETE2019Complete vs Culprit-Only Revascularisation StrategiesORBITA2018Objective Randomised Blinded Investigation with optimal medical Therapy of AngioplastySCOT-HEART2018Scottish COmputed Tomography of the HEART trialEXCEL2016Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main RevascularizationNOBLE2016Nordic-Baltic-British Left Main Revascularisation StudyFREEDOM2012Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel diseaseFAME 22012Fractional flow reserve versus Angiography for Multivessel Evaluation 2PLATO2009Platelet Inhibition and Patient OutcomesFAME2009Fractional Flow Reserve versus Angiography for Multivessel EvaluationSYNTAX2009SYNergy between percutaneous coronary intervention with TAXUS and Cardiac SurgeryTRITON-TIMI 382007Trial to Assess Improvement in Therapeutic OutcomesCOURAGE2007Clinical Outcomes Utilising Revascularisation and Aggressive Drug EvaluationCOMMIT2005ClOpidogrel and Metoprolol in Myocardial Infarction Trial (Second Chinese Cardiac Study, CCS-2)CURE2001Clopidogrel in Unstable Angina to Prevent Recurrent EventsTACTICS-TIMI 182001Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy — TIMI 18HOPE2000Heart Outcomes Prevention EvaluationISIS-21988Second International Study of Infarct Survival